A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies
Clinical trial NCT01957579 · COMPLETED
Trial details
- NCT number
- NCT01957579
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-25
- Primary completion
- 2015-09-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.